Expanding Clinical Pipelines, Contract Manufacturing Adoption, and Automation-Led Process Innovation Fuel Robust Market Growth Globally.
Austin, United States, Feb. 27, 2026 (GLOBE NEWSWIRE) — According to SNS Insider, The Cell & Gene Therapy Manufacturing Services Market size is estimated at USD 15.59 billion in 2025 and is expected to reach USD 74.41 billion by 2035, growing at a CAGR of 16.96% over 2026-2035. Growing demand for cutting-edge therapeutic manufacturing solutions, including viral vector production, cell processing platforms, and gene editing technologies, is driving the global market for cell & gene therapy manufacturing services.
Get a Sample Report of Cell & Gene Therapy Manufacturing Services Market: https://www.snsinsider.com/sample-request/1187
The U.S. Cell & Gene Therapy Manufacturing Services Market is estimated at USD 6.54 billion in 2025 and is expected to reach USD 31.23 billion by 2035, growing at a CAGR of 17.08% during 2026-2035. Due in significant part to the country’s strong biotechnology sector, government backing for regenerative medicine, and sophisticated contract manufacturing infrastructure, the U.S. is the largest market for cell and gene therapy manufacturing services.
Increasing Regulatory Approvals and Clinical Pipeline Expansion to Boost Market Growth Globally
The implementation of expedited regulatory pathways, breakthrough therapy designations, and regenerative medicine advanced therapy standards for accelerated therapy development and commercial manufacturing readiness are the main factors driving the growth of the cell & gene therapy manufacturing services market share. These factors include an increase in regulatory approvals and the expansion of the clinical pipeline. The market’s foundation, the penetration of contract manufacturing and in-house markets, and the expansion of the market share globally are all being driven by these solutions for enhanced therapeutic manufacturing and quality assurance.
High Manufacturing Costs and Technical Complexity Hamper Market Growth Globally
Since many new biotechnology companies struggle to establish specialized manufacturing capabilities and uphold strict quality control standards, the market growth for cell and gene therapy manufacturing services is further constrained by the high manufacturing costs and technical complexity of cell and gene therapy production. Production bottlenecks, restricted therapy accessibility, and a worse return on investment for therapy developers could result from this. As a result, in areas with inadequate manufacturing infrastructure and specialized staff availability, market growth is slowed and therapeutic commercialization timelines suffer.
The cell therapy manufacturing segment accounted for the highest revenue share of approximately 56.72% in 2025, owing to established manufacturing protocols for CAR-T cell therapies. The gene therapy manufacturing segment is anticipated to achieve the highest CAGR of nearly 18.34% during the 2026-2035 period, driven by the increasing number of gene therapy clinical trials and advancements in viral vector production technologies.
By Manufacturing Scale
By 2025, the commercial scale manufacturing segment contributed the largest revenue share of 58.16% due to increasing therapy commercialization. The pre-commercial/R&D scale manufacturing segment is projected to grow at the highest CAGR of about 17.45% between 2026 and 2035 due to the growing number of clinical trial initiations and demand for flexible manufacturing platforms.
By Manufacturing Mode
The contract manufacturing segment accounted for the largest share with about 64.89%, of the cell & gene therapy manufacturing services market and it is also expected to grow with the fastest CAGR or around 17.23% globally owing to capital efficiency advantages.
Need Any Customization Research on Cell & Gene Therapy Manufacturing Services Market, Enquire Now: https://www.snsinsider.com/enquiry/1187
Cell & Gene Therapy Manufacturing Services Market Segmentation
With a compound annual growth rate (CAGR) of 19.27%, Asia Pacific is the market segment with the fastest rate of growth for cell and gene therapy manufacturing services. This growth is driven by the factors, such as government biotechnology development initiatives, increased awareness of the advantages of advanced therapy, and investments in manufacturing infrastructure in developing countries.
North America held the largest revenue share of over 41.94% in 2025 of the cell & gene therapy manufacturing services market due to an established biotechnology industry infrastructure, strong venture capital funding ecosystem, and increased pharmaceutical company investment in regenerative medicine.
Purchase Single User PDF of Cell & Gene Therapy Manufacturing Services Market Report (20% Discount): https://www.snsinsider.com/checkout/1187
5. Cell & Gene Therapy Manufacturing Services Market Segmental Analysis & Forecast, By Therapy Type
6. Cell & Gene Therapy Manufacturing Services Market Segmental Analysis & Forecast, By Manufacturing Scale
7. Cell & Gene Therapy Manufacturing Services Market Segmental Analysis & Forecast, By Manufacturing Mode
8. Cell & Gene Therapy Manufacturing Services Market Segmental Analysis & Forecast, By Workflow
9. Cell & Gene Therapy Manufacturing Services Market Segmental Analysis & Forecast, By Region
Access Complete Report Details of Cell & Gene Therapy Manufacturing Services Market Analysis & Outlook: https://www.snsinsider.com/reports/cell-and-gene-therapy-manufacturing-services-market-1187
[For more information or need any customization research mail us at [email protected]]
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
